Vioxx: The Downfall of a Drug
Merck removed one of the world's best-selling painkillers from the market in 2004 after a study showed Vioxx caused an increased risk of serious cardiovascular events, such as stroke and heart attack.  Now, Merck agrees to pay $4.85B to end thousands of lawsuits.
NPR's Lulu Garcia-Navarro speaks with Jennifer Heissenbuttal about her sister AshLee DeMarinis, a teacher who died from COVID-19.